{"id":206828,"name":"HORIZON THERAPEUTICS USA INC","slug":"horizon-therapeutics-usa-inc","state":"IL","country":"United States of America","description":"pharmaceutical company","totalSpending":1170000,"filings":16,"yearlySpending":[{"year":2020,"income":130000},{"year":2021,"income":320000},{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":80000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"PHA","display":"Pharmacy"},{"code":"LBR","display":"Labor Issues/Antitrust/Workplace"}],"firms":["RICCHETTI INCORPORATED"],"lobbyists":["JEFF RICCHETTI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["CMS line extension regulations\nparameters of Medicaid rebates and 340(b) drug pricing program","CMS line extension regulations\nparameters of Medicaid rebates and 340(b) drug pricing program","CMS proposed rule regarding product line extensions","CMS proposed rule regarding product line extensions","Issues related to pharmaceutical industry, generally"]}